logo
Select company
Select metric
$ -4.17EBITDA per Share
VS
Market
6
Sector
14
Industry
18
History
75
$ 24.21Close
$ 11.02 - $ 25.71 52-Week Range
Ticker Information

Ticker

VRDN

Company Name

VIRIDIAN THERAPEUTICS INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

VIRIDIAN THERAPEUTICS INC - EBITDA per Share Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

VRDN - EBITDAPS Historical data
DateEarnings Before Interest Taxes & Depreciation Amortization (EBITDA)EBITDA per ShareShare FactorWeighted Average Shares
6/30/2025$ -340.63M$ -4.17181.59M
3/31/2025$ -304.58M$ -3.74181.34M
12/31/2024$ -266.19M$ -3.92167.89M
9/30/2024$ -253.24M$ -3.81166.42M
6/30/2024$ -224.54M$ -3.52163.85M
3/31/2024$ -215.27M$ -3.52161.1M
12/31/2023$ -235.32M$ -5.26144.76M
9/30/2023$ -215.04M$ -4.93143.65M
6/30/2023$ -196.88M$ -4.55143.25M
3/31/2023$ -171.31M$ -4.06142.24M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • VIRIDIAN THERAPEUTICS INC's latest trailing twelve months (TTM) EBITDAPS stands at $ -7.89.
  • Over the past 5 years, VIRIDIAN THERAPEUTICS INC's average EBITDAPS has been $ -7.45.
  • The median EBITDAPS for VIRIDIAN THERAPEUTICS INC during this period was $ -4.12
  • VIRIDIAN THERAPEUTICS INC reached its highest EBITDAPS over the past 5 years at $ -3.32.
  • The lowest EBITDAPS recorded by VIRIDIAN THERAPEUTICS INC in the same timeframe $ -30.92

VIRIDIAN THERAPEUTICS INC's EBITDAPS vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

EBITDAPS Benchmarks
CompanyEBITDAPS
JANX : JANUX THERAPEUTICS INC $ -1.67BHVN : BIOHAVEN LTD $ -7.4EWTX : EDGEWISE THERAPEUTICS INC $ -1.41ETNB : 89BIO INC $ -2.8CLNN : CLENE INC $ -2.6ABEO : ABEONA THERAPEUTICS INC $ 1.52DYN : DYNE THERAPEUTICS INC $ -3.61VERA : VERA THERAPEUTICS INC $ -3.27COEP : COEPTIS THERAPEUTICS HOLDINGS INC $ -2.41CDTX : CIDARA THERAPEUTICS INC $ -7.47

Similar metrics to Shares WA:

Definition of EBITDA per Share

[Calculation] The amount of earnings before interest, taxes, depreciation, and amortization attributed to each share, calculated as [EBITDA] divided by the weighted average number of shares [SharesWA] after adjusting for [ShareFactor].
EBITDA / (Shares WA * Share Factor)
(=) EBITDAPS EBITDAPS for VIRIDIAN THERAPEUTICS INC is calculated as follows: EBITDA [ $ -29.33M ] / (Shares WA [ 3.72M ] * Share Factor [ 1 ])
(=) EBITDAPS [ $ -7.89 ]

VRDN - EBITDA per Share, Last 5 years

$ -30.92

Minimum

Dec 31, 2020

$ -3.32

Maximum

Mar 31, 2022

$ -7.45

Average

$ -4.12

Median

EBITDAPS Benchmark Analysis

 The chart above depicts the distribution of EBITDAPS for companies in the Total Stock Market. The average EBITDAPS of the companies is $ 2.01 with a standard deviation of $ 4.26.
The following table provides additional summary stats:
EBITDAPS in the Market:
filtered constituents3.78K
min$ -10.86
max$ 13.95
average$ 2.01
median$ 0.99
std$ 4.26